Evidence-Based GI
Risankizumab Is Superior to Ustekinumab for Induction and Maintenance of Crohn’s Disease: The SEQUENCE Trial Sara Ghoneim, MD1 and Bharati…
Vonoprazan is Efficacious for Non-Erosive Reflux Disease (NERD): An Alternative for PPI-Resistant NERD Patients? Christopher Vélez, MD Associate Program Director,…
ERCP with Extracorporeal Shock-Wave Lithotripsy For Chronic Pancreatitis: Is It A “Sham” for Improving Pain? Margaret J Zhou, MD, MS1…
In Case You Missed It 2022 ACG Clinical Guideline Gastroparesis: Limited Evidence-Based Options Elie Al Kazzi, MD, MPH,1 Philip…
Tirzepatide Produces NASH Resolution and Decreases Fibrosis: Results from the SYNERGY-NASH Trial Nicole E. Rich, MD MSCS Assistant Professor, Associate…
Oral Vonoprazan for Prevention of High-Risk Peptic Ulcer Rebleeding: A Better Alternative Than IV PPIs? Philip Schoenfeld, MD, MSEd, MSc…
Long-Term Efficacy and Safety of Ustekinumab for Ulcerative Colitis: 4-Year Data from the UNIFI Long-Term Maintenance Study Rahul Dalal, MD,…
Do Not Extend Interval Between CRC Screening Colonoscopies from 10 to 15 Years: Perils of Administrative Databases Philip Schoenfeld, MD,…
Stemming the Tide: Is Long-Acting Octreotide Injection Better Than Standard of Care for Angiodysplasia-Related GI Bleeding? Philip N. Okafor, MD,…
Multi-Target Stool RNA Test for CRC Screening: When Should You Use It? Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus),…